Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
Nuno Marques(Hospital do Espírito Santo), Luís R. Lopes(Barts Health NHS Trust), Olga Azevedo(British Heart Foundation), Carolina Lourenço(Hospitais da Universidade de Coimbra), Ana Rita Almeida(Hospital Garcia de Orta), Inês Cruz(Hospital Garcia de Orta), Dina Bento(Algarve Biomedical Center)
Cited by 18
Related Papers
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|356
Assessing cognitive decline in the aging brain: lessons from rodent and human studies
|npj Aging|2023|170
Prediction of Sarcomere Mutations in Subclinical Hypertrophic Cardiomyopathy
|Circulation Cardiovascular Imaging|2014|111
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
|Journal of the American College of Cardiology|2020|104
Using ChatGPT in Software Requirements Engineering: A Comprehensive Review
|Future Internet|2024|94